arginine and Cranial Nerve II Diseases

arginine has been researched along with Cranial Nerve II Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fish, M; Hack, M; Majounie, E; Morris, HR; Newsway, V; Rohrer, JD; Warren, JD; Williams, N1
Bhattacharya, SK; Bonilha, VL; Crabb, JS; Crabb, JW; Gu, X; Takahara, H1

Other Studies

2 other study(ies) available for arginine and Cranial Nerve II Diseases

ArticleYear
Perry syndrome due to the DCTN1 G71R mutation: a distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure.
    Movement disorders : official journal of the Movement Disorder Society, 2010, Apr-30, Volume: 25, Issue:6

    Topics: Arginine; Behavioral Symptoms; DNA Mutational Analysis; Dopamine Agents; Dynactin Complex; Glycine; Humans; Levodopa; Male; Microtubule-Associated Proteins; Middle Aged; Neuropsychological Tests; Optic Nerve Diseases; Parkinsonian Disorders; Respiratory Insufficiency

2010
Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis.
    Investigative ophthalmology & visual science, 2006, Volume: 47, Issue:6

    Topics: Aged; Aged, 80 and over; Animals; Arginine; Astrocytes; Blotting, Western; Citrulline; Disease Models, Animal; Down-Regulation; Female; Glaucoma, Open-Angle; Humans; Hydrolases; Immunohistochemistry; Male; Methylation; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Middle Aged; Optic Nerve Diseases; Proteomics; Rats; Rats, Sprague-Dawley; RNA, Messenger

2006